Cellular Uptake of Liposomal Daunorubicin and the Induction of Apoptosis

Author： Gray Atherton   Landfair Darla J.   Wiles Marc E.  

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.6, Iss.4, 1999-10, pp. : 213-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal daunorubicin + cytarabine effective in AML

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation

By Kang Myung J.   Kim Bo G.   Eum Jae Y.   Park Sang H.   Choi Sun E.   An Jae J.   Jang Sang H.   Eum Won S.   Lee Jaehwi   Lee Min W.   Kang Kyungho   Oh Chil H.   Choi Soo Y.   Choi Young W.  

Journal of Drug Targeting, Vol. 19, Iss. 7, 2011-08 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas

By Phan Vu   Walters Jarvis   Brownlow Bill   Elbayoumi Tamer  

Journal of Drug Targeting, Vol. 21, Iss. 10, 2013-12 ,pp. : 1001-1011

Informa Healthcare

Access to resources Recommend Favorite

Disposition of Liposomal Daunorubicin During Cotreatment with Cytarabine in Patients with Leukaemia

By Pea F.  

Clinical Pharmacokinetics, Vol. 42, Iss. 9, 2003-01 ,pp. : 851-862

Adis International

Access to resources Recommend Favorite

Liposomal daunorubicin + cytarabarine valid for leukaemia?

By  

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite